Midstream Health secured $20 million in Series A funding to help health systems add financial stability as value-based care expands. The round was led by Valtruis and included participation from Andreessen Horowitz (a16z), Foundry, and CommonSpirit Ventures. The company’s financing underlines continued investor appetite for infrastructure and payment-adjacent tools that can support provider performance. For biopharma stakeholders, such funding can influence the contracting environment and the operational capacity of care delivery systems that increasingly shape real-world utilization and outcomes.